
Gaudium IVF & Women Health
Open Date
Feb 20, 2026
Close Date
Feb 24, 2026
Min Investment
₹14,931
Lot Size
189 Shares
Issue Size
₹165 Cr
Price Range
₹75 - ₹79
Listing Date
Feb 27, 2026
IPO Doc
RHP PDFAbout Gaudium IVF & Women Health
Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization treatments throughout India and have expanded into several states utilizing a hub-and-spoke model. The company has more than thirty locations. These include seven hubs (centres) and twenty-eight spokes. The strategic alliance between the organization and Infertility Experts, referred to as Spokes, was forged in order to meet the mutual goal of spreading awareness about Assisted Reproductive Technology or ART and In Vitro Fertilization or IVF treatments.The patients come from various countries such as Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman. The company has hubs in Delhi, two Janakpuri and Kailash Colony; Mumbai; Khar West; Ludhiana; Srinagar; Patna; and Bangalore, covering all important locations across the subcontinent. This company offers a range of specialized fertility services: In Vitro Fertilization, Intracytoplasmic Sperm Injection, Intrauterine Insemination, and ovulation induction. Our treatments are specifically directed for a variety of infertility conditions in both males and females. We also provide comprehensive gynaecological care for PCOD/PCOS and endometriosis and high-risk pregnancy management for women with complex fertility history or health conditions. These facilities cover a wide scope of male infertility treatments, right from advanced sperm retrieval techniques.
Checklist Quality Analysis
Revenue Growth
Company Valuation
Earning Expansion
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily.
Gaudium IVF & Women Health IPO - Issue Objectives
The company will use approximately ₹50 crore for the establishment of new IVF Centers. The company will use ₹20 crore for repayment of certain outstanding loans availed by it. Part of the IPO proceeds will be used for general corporate purposes and issue expenses
Capital expenditure
55.5%
Repayment of borrowings
22.2%
General corporate purposes
22.3%
Capital expenditure
The company will use approximately ₹50 crore for the establishment of new IVF Centers.
Repayment of borrowings
The company will use ₹20 crore for repayment of certain outstanding loans availed by it.
General corporate purposes
Part of the IPO proceeds will be used for general corporate purposes and issue expenses
IPO Subscription Status
Financials of Gaudium IVF & Women Health
In Cr.
Revenue: ₹49.75
EBITDA: ₹18.95
Profit: ₹12.51
| Key Performance Indicator | 30-Sep-25 (In Cr.) | 31-Mar-25 (In Cr.) | 31-Mar-24 (In Cr.) | 31-Mar-23 (In Cr.) |
|---|---|---|---|---|
| Revenue | 49.75 | 70.96 | 48.15 | 44.26 |
| EBITDA | 18.95 | 28.63 | 19.27 | 20.07 |
| Expenses | ||||
| Profit After Tax | 12.51 | 19.13 | 10.32 | 13.53 |
| Assets | 106.62 | 88.51 | 51.01 | 36.63 |
| Net Worth | 58.85 | 46.30 | 26.99 | 22.73 |
| Reserves | 28.16 | 15.60 | 26.00 | 21.74 |
| Borrowing | 22.51 | 18.93 | 15.73 | 9.78 |
Gaudium IVF & Women Health - Promoter(s)
Dr. Manika Khanna
Dr. Peeyush Khanna
Vishad Khanna
99.99%
71.30%
About Strength & Risks
Contact Details
Gaudium IVF & Women Health
B1/51, Janak Puri, B-1, New Delhi, New Delhi, 110058
Registrar Contact Details
Bigshare Services Pvt.Ltd.
Gaudium IVF & Women Health IPO - FAQs
Live IPOs
CMR Green Technologies
Vahh Chemicals
UHM Vacation
| Companies Name | Open - Close | Issue Size | Min. Qty | Issue Price | Apply |
|---|---|---|---|---|---|
CMR Green Technologies Mainboard BSE NSE | 3rd Jun 2026 - 5th Jun 2026 | 630.88 Cr | 78 Shares | ₹ 182.00 | |
Vahh Chemicals SME | 4th Jun 2026 - 8th Jun 2026 | 13.45 Cr | 2000 Shares | ₹ 60.00 | |
UHM Vacation SME | 4th Jun 2026 - 8th Jun 2026 | 36.02 Cr | 800 Shares | ₹ 166.00 | |
Hexagon Nutrition Mainboard | 5th Jun 2026 - 9th Jun 2026 | 138.87 Cr | 333 Shares | ₹ 42.00 |